PT1077930E - Derivados de benzamida para o tratamento de doencas mediadas por citocinas - Google Patents
Derivados de benzamida para o tratamento de doencas mediadas por citocinasInfo
- Publication number
- PT1077930E PT1077930E PT99921018T PT99921018T PT1077930E PT 1077930 E PT1077930 E PT 1077930E PT 99921018 T PT99921018 T PT 99921018T PT 99921018 T PT99921018 T PT 99921018T PT 1077930 E PT1077930 E PT 1077930E
- Authority
- PT
- Portugal
- Prior art keywords
- cytokines
- treatment
- diseases mediated
- benzamide derivatives
- 6alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810356.7A GB9810356D0 (en) | 1998-05-15 | 1998-05-15 | Amide derivatives |
GBGB9905970.1A GB9905970D0 (en) | 1999-03-17 | 1999-03-17 | Amide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1077930E true PT1077930E (pt) | 2005-03-31 |
Family
ID=26313677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99921018T PT1077930E (pt) | 1998-05-15 | 1999-05-11 | Derivados de benzamida para o tratamento de doencas mediadas por citocinas |
Country Status (23)
Country | Link |
---|---|
US (1) | US6465455B1 (pt) |
EP (1) | EP1077930B1 (pt) |
JP (1) | JP2003505337A (pt) |
KR (1) | KR100628284B1 (pt) |
CN (1) | CN1188389C (pt) |
AT (1) | ATE282023T1 (pt) |
AU (1) | AU748397B2 (pt) |
BR (1) | BR9910467A (pt) |
CA (1) | CA2328699A1 (pt) |
DE (1) | DE69921804T2 (pt) |
ES (1) | ES2230853T3 (pt) |
HK (1) | HK1033753A1 (pt) |
HU (1) | HUP0102367A3 (pt) |
ID (1) | ID27285A (pt) |
IL (1) | IL139710A (pt) |
NO (1) | NO20005766L (pt) |
NZ (1) | NZ507143A (pt) |
PL (1) | PL197181B1 (pt) |
PT (1) | PT1077930E (pt) |
RU (1) | RU2205823C2 (pt) |
SK (1) | SK286247B6 (pt) |
TR (1) | TR200003355T2 (pt) |
WO (1) | WO1999059960A1 (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
US7772432B2 (en) | 1991-09-19 | 2010-08-10 | Astrazeneca Ab | Amidobenzamide derivatives which are useful as cytokine inhibitors |
IL134723A0 (en) | 1997-09-23 | 2001-04-30 | Zeneca Ltd | Amide derivatives for the treatment of diseases mediated by cytokines |
AU749293B2 (en) | 1998-05-15 | 2002-06-20 | Astrazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
BR9910467A (pt) | 1998-05-15 | 2001-01-09 | Astrazeneca Ab | Composto derivado de amida, processo para a preparação do mesmo, composição farmacêutica, e, uso de um composto derivado de amida |
TR200100300T2 (tr) | 1998-08-04 | 2001-07-23 | Astrazeneca Ab | Sitokinlerin üretiminde engelleyici olarak kullanışlı amid türevleri |
WO2000010563A1 (en) | 1998-08-20 | 2000-03-02 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
PL346854A1 (en) | 1998-09-25 | 2002-03-11 | Astrazeneca Ab | Benzamide derivatives and their use as cytokine inhibitors |
BR0009041A (pt) * | 1999-03-17 | 2001-12-26 | Astrazeneca Ab | Derivado de amida, processo para a preparação deum derivado de amida, composição farmacêutica,uso de um derivado de amida, e, método paratratar doenças ou quadros clìnicos mediados porcitocinas |
ES2219319T3 (es) | 1999-03-17 | 2004-12-01 | Astrazeneca Ab | Derivados de amida. |
GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
JP2003514899A (ja) | 1999-11-23 | 2003-04-22 | スミスクライン・ビーチャム・コーポレイション | CSBP/p38キナーゼ阻害剤としての3,4‐ジヒドロ−(1H)−キナゾリン−2−オン化合物 |
US6943161B2 (en) | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
US8263657B2 (en) * | 2000-12-18 | 2012-09-11 | Institute Of Medicinal Molecular Design, Inc. | Inhibitors against the production and release of inflammatory cytokines |
JP4361273B2 (ja) | 2001-02-27 | 2009-11-11 | アメリカ合衆国 | 潜在的な血管形成阻害剤としてのサリドマイド類似体 |
WO2003103654A1 (ja) * | 2002-06-10 | 2003-12-18 | 株式会社医薬分子設計研究所 | NF−κB活性化阻害剤 |
WO2004004703A1 (ja) * | 2002-07-04 | 2004-01-15 | Mitsui Chemicals, Inc. | メタフェニレンジアミン誘導体 |
ES2278170T3 (es) | 2002-07-09 | 2007-08-01 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias. |
US8952895B2 (en) | 2011-06-03 | 2015-02-10 | Apple Inc. | Motion-based device operations |
CN1867331B (zh) | 2003-09-17 | 2010-05-26 | 美国政府健康及人类服务部 | 作为TNF-α调节剂的沙利度胺类似物 |
GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
JP5324785B2 (ja) | 2005-10-28 | 2013-10-23 | 武田薬品工業株式会社 | 複素環アミド化合物及びその用途 |
WO2007059157A1 (en) * | 2005-11-14 | 2007-05-24 | Genentech, Inc. | Bisamide inhibitors of hedgehog signaling |
AU2007238785B2 (en) | 2006-04-13 | 2013-02-07 | Agnieszka Ambrozak | Tetrahalogenated compounds useful as inhibitors of angiogenesis |
US7671058B2 (en) * | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
WO2008089034A2 (en) * | 2007-01-11 | 2008-07-24 | Kemia, Inc. | Cytokine inhibitors |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
US8927725B2 (en) | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
CN104326937B (zh) * | 2014-09-03 | 2016-08-24 | 天津市肿瘤研究所 | 抗肿瘤化合物及其医药用途 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1903899A (en) | 1933-04-18 | Cabboxylic acid abylides oe the benzene sebies and process oe making | ||
US1909960A (en) | 1929-08-06 | 1933-05-23 | Du Pont | Intermediate for azo dyes |
DE2812252A1 (de) | 1978-03-21 | 1979-10-04 | Bayer Ag | 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel |
US4524168A (en) | 1981-11-18 | 1985-06-18 | Ciba-Geigy Corporation | Process for the mass coloration of polymers |
US4749729A (en) | 1984-06-21 | 1988-06-07 | American Cyanamid Company | Epoxy resin compositions curable above 160 F. and below 250 F. |
AU2552492A (en) | 1991-08-23 | 1993-03-16 | United States of America as represented by The Secretary Department of Health and Human Services, The | Raf protein kinase therapeutics |
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
EP0871444A4 (en) | 1995-08-10 | 1999-01-13 | Merck & Co Inc | 2.5 SUBSTITUTED ARYL PYRROL, THE COMPOSITIONS THAT CONTAIN AND THE USE THEREOF |
DE69634822T2 (de) | 1995-08-22 | 2006-04-27 | Japan Tobacco Inc. | Amid-verbindungen und ihre anwendung |
GB9604926D0 (en) | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
JP2001506230A (ja) * | 1996-08-09 | 2001-05-15 | スミスクライン・ビーチャム・コーポレイション | 新規ピペラジン含有化合物 |
GB9623833D0 (en) | 1996-11-16 | 1997-01-08 | Zeneca Ltd | Chemical compound |
IL134723A0 (en) * | 1997-09-23 | 2001-04-30 | Zeneca Ltd | Amide derivatives for the treatment of diseases mediated by cytokines |
GB9809347D0 (en) | 1998-05-05 | 1998-07-01 | Reckitt & Colmann Prod Ltd | Compositions |
BR9910467A (pt) | 1998-05-15 | 2001-01-09 | Astrazeneca Ab | Composto derivado de amida, processo para a preparação do mesmo, composição farmacêutica, e, uso de um composto derivado de amida |
AU749293B2 (en) | 1998-05-15 | 2002-06-20 | Astrazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
TR200100300T2 (tr) | 1998-08-04 | 2001-07-23 | Astrazeneca Ab | Sitokinlerin üretiminde engelleyici olarak kullanışlı amid türevleri |
PL346854A1 (en) | 1998-09-25 | 2002-03-11 | Astrazeneca Ab | Benzamide derivatives and their use as cytokine inhibitors |
CN1158266C (zh) | 1998-10-01 | 2004-07-21 | 阿斯特拉曾尼卡有限公司 | 化合物 |
BR0009041A (pt) | 1999-03-17 | 2001-12-26 | Astrazeneca Ab | Derivado de amida, processo para a preparação deum derivado de amida, composição farmacêutica,uso de um derivado de amida, e, método paratratar doenças ou quadros clìnicos mediados porcitocinas |
ES2219319T3 (es) | 1999-03-17 | 2004-12-01 | Astrazeneca Ab | Derivados de amida. |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
-
1999
- 1999-05-11 BR BR9910467-9A patent/BR9910467A/pt not_active Application Discontinuation
- 1999-05-11 SK SK1717-2000A patent/SK286247B6/sk unknown
- 1999-05-11 RU RU2000131610/04A patent/RU2205823C2/ru not_active IP Right Cessation
- 1999-05-11 AU AU38392/99A patent/AU748397B2/en not_active Ceased
- 1999-05-11 EP EP99921018A patent/EP1077930B1/en not_active Expired - Lifetime
- 1999-05-11 KR KR1020007012666A patent/KR100628284B1/ko not_active IP Right Cessation
- 1999-05-11 PT PT99921018T patent/PT1077930E/pt unknown
- 1999-05-11 IL IL13971099A patent/IL139710A/xx not_active IP Right Cessation
- 1999-05-11 WO PCT/GB1999/001491 patent/WO1999059960A1/en active IP Right Grant
- 1999-05-11 CA CA002328699A patent/CA2328699A1/en not_active Abandoned
- 1999-05-11 ID IDW20002240A patent/ID27285A/id unknown
- 1999-05-11 PL PL344185A patent/PL197181B1/pl not_active IP Right Cessation
- 1999-05-11 JP JP2000549579A patent/JP2003505337A/ja not_active Withdrawn
- 1999-05-11 TR TR2000/03355T patent/TR200003355T2/xx unknown
- 1999-05-11 DE DE69921804T patent/DE69921804T2/de not_active Expired - Fee Related
- 1999-05-11 AT AT99921018T patent/ATE282023T1/de not_active IP Right Cessation
- 1999-05-11 CN CNB998061441A patent/CN1188389C/zh not_active Expired - Fee Related
- 1999-05-11 HU HU0102367A patent/HUP0102367A3/hu unknown
- 1999-05-11 ES ES99921018T patent/ES2230853T3/es not_active Expired - Lifetime
- 1999-05-11 US US09/674,428 patent/US6465455B1/en not_active Expired - Fee Related
- 1999-05-11 NZ NZ507143A patent/NZ507143A/en unknown
-
2000
- 2000-11-14 NO NO20005766A patent/NO20005766L/no unknown
-
2001
- 2001-06-20 HK HK01104299A patent/HK1033753A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1077930B1 (en) | 2004-11-10 |
EP1077930A1 (en) | 2001-02-28 |
HK1033753A1 (en) | 2001-09-21 |
NZ507143A (en) | 2003-08-29 |
CA2328699A1 (en) | 1999-11-25 |
PL197181B1 (pl) | 2008-03-31 |
HUP0102367A2 (hu) | 2001-10-28 |
ATE282023T1 (de) | 2004-11-15 |
NO20005766L (no) | 2001-01-12 |
AU3839299A (en) | 1999-12-06 |
RU2205823C2 (ru) | 2003-06-10 |
CN1359371A (zh) | 2002-07-17 |
NO20005766D0 (no) | 2000-11-14 |
DE69921804T2 (de) | 2005-10-27 |
DE69921804D1 (de) | 2004-12-16 |
WO1999059960A1 (en) | 1999-11-25 |
ES2230853T3 (es) | 2005-05-01 |
AU748397B2 (en) | 2002-06-06 |
BR9910467A (pt) | 2001-01-09 |
KR100628284B1 (ko) | 2006-09-27 |
JP2003505337A (ja) | 2003-02-12 |
SK17172000A3 (sk) | 2001-04-09 |
CN1188389C (zh) | 2005-02-09 |
SK286247B6 (sk) | 2008-06-06 |
KR20010043547A (ko) | 2001-05-25 |
TR200003355T2 (tr) | 2001-03-21 |
ID27285A (id) | 2001-03-22 |
IL139710A0 (en) | 2002-02-10 |
IL139710A (en) | 2005-07-25 |
HUP0102367A3 (en) | 2002-11-28 |
PL344185A1 (en) | 2001-10-08 |
US6465455B1 (en) | 2002-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1077930E (pt) | Derivados de benzamida para o tratamento de doencas mediadas por citocinas | |
PT1017378E (pt) | Derivados de amida para o tratamento de doencas mediadas por citoquinas | |
MY142177A (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
NZ509318A (en) | Amide derivatives, their preparation and use in the treatment of diseases mediated by cytokines | |
ES2080900T3 (es) | Derivados piranicos utiles como inhibidores de 5-lipoxigenasa. | |
GB8823731D0 (en) | Biologically active compounds | |
NO920035D0 (no) | Trifluormetylketon-derivater, og deres fremstilling og anvendelse | |
ECSP045469A (es) | El uso de cianopirrolidinas sustituidas y preparaciones de combinacion que las contienen para tratar hiperlipidemia y enfermedades asociadas | |
ES2164109T3 (es) | Derivados de n-(3-piperidinilcarbonil)-beta-alanina como antagonistas de paf. | |
NZ308398A (en) | 2-amino benzoxazin-4-one derivatives and medicaments | |
DE69814612D1 (de) | Stoffe zur hemmung der bildung des pterygiums und seines postoperative wiederauftretens | |
DE69224497T2 (de) | Faktor C2a des Antibiotikums CE 2270 | |
ATE88176T1 (de) | 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung. | |
ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
DK0677513T3 (da) | Octahydro-2-naphthalencarboxylsyrederivat, dets fremstilling og anvendelse | |
RU95117692A (ru) | Щелочные соли амидов оротовой кислоты и аминокислот, обладающие гипертензивной активностью | |
UA82996C2 (ru) | Производные бензамида, полезные в качестве ингибиторов деацетилазы гистонов, способ их получения (варианты), фармацевтическая композиция на их основе | |
ECSP900707A (es) | Derivados de aminoacidos |